Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: Insights into the regulation of these peptides

Clinical Endocrinology

Volumn 55, Issue 4, 2001, Pages 469-475

  Renehan, Andrew G ^a   Toogood, Andrew A ^a   David Ryder, W ^a   Jones, Jenny ^b   Potten, Christopher S ^a   O'Dwyer, Sarah T ^a   Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; SOMATOMEDIN; SOMATOMEDIN 1; SOMATOMEDIN 2; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0034797758     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01380.x     Document Type: Article

References (35)

1. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer
2. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
3. Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: Circulating levels of IGF-I and IGF-binding proteins in transgenic mice
4. Clinical studies of IGFBP-2 by radioimmunoassay
5. Insulin-like growth factor binding proteins and their role in controlling IGF actions
6. Variables controlling the secretion of insulin-like growth factor-binding protein-2 in normal human subjects
7. Robust locally weighted regression and smoothing scatterplots
8. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients
9. Human growth hormone and human aging
10. Insulin-like growth factor binding proteins (IGFBPs) in acromegaly
11. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
12. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly
13. Serum insulin-like growth factor II in chronic liver disease
14. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
15. The IGF-II enigma
16. Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjects
17. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
18. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid
19. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
20. Hypothalamic dysfunction in 'cured' acromegaly is treatment modality dependent
21. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
22. Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours
23. The prevalence and characteristics of colorectal neoplasia in acromegaly
24. Elevated serum insulin-like growth factor (IGF)-II and binding protein 2 in patients with colorectal cancer
25. More about: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF binding protein-3
26. Circulating insulin-like growth factor (IGF)-II and colorectal adenomas
27. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults
28. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children
29. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics
30. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease
31. What is the function of IGF-II in postnatal life? Answers from transgenic mouse models
32. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
33. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia
34. Identification and characterization of insulin-like growth factor-binding proteins
35. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia